Burkman R T, Bell W R, Atienza M F, King T M
Am J Obstet Gynecol. 1977 Mar 1;127(5):533-6. doi: 10.1016/0002-9378(77)90450-1.
Coagulation changes, usually subclinical, have been reported in association with the induction of midtrimester abortion by the administration of intra-amniotic hypertonic sodium chloride, hyperosmolar urea, hyperosmolar urea plus prostaglandin F2alpha, and hyperosmolar ura or hypertonic glucose plus prostaglandin E2. In addition, clinically significant coagulopathy has been described in association with the administration of hypertonic sodium chloride. This study details a three-year experience involving 3,034 cases of midtrimester elective abortion and describes six cases of coagulopathy in association with the administration of hypertonic sodium chloride and two cases in association with the administration of hyperosmolar urea. The significance of these findings and etiologic considerations are discussed.
已有报道称,通过羊膜腔内注射高渗氯化钠、高渗尿素、高渗尿素加前列腺素F2α以及高渗尿素或高渗葡萄糖加前列腺素E2来引产中期妊娠,通常会出现亚临床的凝血变化。此外,还描述了与高渗氯化钠给药相关的具有临床意义的凝血病。本研究详细介绍了一项为期三年、涉及3034例中期妊娠选择性流产的经验,并描述了6例与高渗氯化钠给药相关的凝血病病例以及2例与高渗尿素给药相关的病例。讨论了这些发现的意义和病因学考虑因素。